CompletedPHASE2, PHASE3NCT01441557

Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

Studying Botulism

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire, Amiens
Principal Investigator
Herve DUPONT, Md, PhD
CHU Amiens
Intervention
3,4-diaminopyridine(drug)
Enrollment
3 enrolled
Eligibility
18 years · All sexes
Timeline
2011 – 2012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01441557 on ClinicalTrials.gov

Other trials for Botulism

Additional recruiting or active studies for the same condition.

See all trials for Botulism →

← Back to all trials